Guideline-directed medical therapy in real-world heart failure patients with low blood pressure and renal dysfunction

• Published in: Clinical research in cardiology Vol. 110; no. 7; pp. 1051 - 1062
• Main Authors: Chen, Xiaojing, Cui, Xiaotong, Thunström, Erik, Pivodic, Aldina, Dahlström, Ulf, Fu, Michael
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.07.2021; Springer Nature B.V
• Subjects: Angiotensin; Angiotensin II; Angiotensin-converting enzyme inhibitors; Blood pressure; Cardiology; Cardiology and Cardiovascular Disease; Congestive heart failure; Epidermal growth factor receptors; Glomerular filtration rate; Heart failure; Hemoglobin; Kardiologi och kardiovaskulära sjukdomar; Medical prognosis; Medicine; Medicine & Public Health; Mortality; Original Paper; Patients; Peptidyl-dipeptidase A; Receptors; Renal function; Therapy; Heart failure; Low blood pressure; Guideline-directed medical therapy; Mortality; Renal dysfunction

Background Among patients with heart failure and reduced ejection fraction (HFrEF), angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (ACEI/ARB), β-blockers (BB) and mineralocorticoid receptor antagonist (MRA) are known as guideline-directed medical therapy to improve prognos...